Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in STOK — Stoke Therapeutics, Inc.

CIK 902219 Boston, MA

Position in STOK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$115,151,526
+$14,355,538 QoQ
Shares Held
3,519,301
+13.7% QoQ
Ownership
5.45%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#6
of 198 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 0% Shared 93% None 7%

Common Shares in STOK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. STOK ranks #32 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in STOK

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $115,151,526 3,519,301
2026-03-31 $100,795,988 3,095,700
2025-12-31 $23,354,256 735,799
2025-09-30 $17,337,194 737,753
2025-06-30 $1,555,697 137,066
2025-03-31 $904,133 135,960
2024-12-31 $1,486,976 134,812
2024-09-30 $1,683,422 136,975
2024-06-30 $1,940,521 143,636
2024-03-31 $1,935,238 143,351
2023-09-30 $686,867 174,332
2023-06-30 $1,799,530 169,288
2023-03-31 $1,673,471 200,897
2022-12-31 $5,649,256 612,054
2022-09-30 $16,222,042 1,263,399
2022-06-30 $16,619,671 1,258,113
2022-03-31 $25,009,819 1,188,115
2020-09-30 $1,833,577 54,750
2020-06-30 $368,125 15,448
2020-03-31 $3,004,020 131,180